Latest news with #Zaza
CairoScene
02-07-2025
- Entertainment
- CairoScene
Lege-Cy & Ziad Zaza Drop Arabic Pop Banger 'Wala Meen'
Co-produced by Kingoo and Zaza's long-time collaborator Ismail Nosrat, the track showcases a noticeable sonic shift for both artists Jul 02, 2025 After a week of teasing on social media, starting with a studio photo before sending TikTok into a frenzy with short snippets of the new single, Zaza and Lege-Cy have finally released their long-awaited collaboration, 'Wala Meen', and it might just become the soundtrack of the summer for us. Co-produced by Kingoo and Zaza's long-time collaborator Ismail Nosrat, the track showcases a noticeable sonic shift for both artists. Known for their sharp wordplay and punchy delivery, the Egyptian rap stars step out of their usual lanes, blurring the lines between trap and Arabic pop to explore a more melodic, catchy sound, all wrapped in slick, bass-driven production imbued with distortion and trap muscle. This isn't their first foray into a softer sound. Earlier this year, Lege-Cy dropped 'Law Nasyany', also produced by Nosrat, which hinted at his expanding range. Meanwhile, for Zaza, 'Wala Meen' is another step in his series of sonic experiments, as he went from the rage-fueled energy of '525' to the minimalism of 'EZ' and his dabbling in shaabi influences on tracks like 'Ana Ayesh West Modmenen'.
Rudaw Net
01-07-2025
- Politics
- Rudaw Net
Syrian government under fire for arresting Kurdish journalist
Also in Middle East Turkish intel chief discusses PKK with Kurdish leaders in Erbil Family of two Iraqis killed in Turkey demand justice Ministry confirms two Iraqis killed in Turkey Yazidi young man rescued 11 years after ISIS captivity A+ A- ERBIL, Kurdistan Region - The recent arrest of a veteran Kurdish journalist by the Syrian interim authorities in Damascus has sparked widespread outrage among international and local rights groups and political parties. His whereabouts remain unknown. Hassan Zaza, the editor-in-chief of Noos Social media outlet, was arrested in Damascus on Friday for unknown reasons and taken to an unknown location, according to the Committee to Protect Journalists (CPT). 'The secret detention of journalist Hassan Zaza, without any explanation from Syrian officials, reflects a nationwide pattern of press intimidation,' Sara Qudah, CPJ's regional director, was cited as saying in a CPJ statement on Monday. 'Syrian authorities must immediately disclose Zaza's whereabouts, ensure his safety, and drop any charges related to his journalistic activities.' Mohammad al-Saleh, Director of Press Relations at Syria's Ministry of Information, confirmed Zaza's detention to the CPJ, stating that it was related to "security concerns" and that it had nothing to do with his journalistic work. He added that if Zaza is not found guilty, he could be freed this week. Several Syrian rights groups and political parties have condemned Zaza's arrest. The Kurdish-held autonomous administration in north and East Syria (Rojava) said in a statement on Saturday that Zaza's arrest is a "clear violation" of international human rights. "We consider this action an assault on press freedoms," it added, calling for his immediate release. Kurdistan Democratic Party of Syria, Syrian Kurdish Journalists Network, and Free Media Union were among political parties and rights groups condemning the arrest of Zaza. Zaza was a senior member of Free Media Union. 'We still have no information about his whereabouts or the reason for his arrest,' Avin Ibrahim, co-chair of the Rojava-based Free Media Union, told CPJ. 'The Syrian government bears full responsibility for the safety of our detained colleague Hassan Zaza, as well as any journalist who may be at risk in the future. These ongoing violations against journalists must end.'
Shafaq News
28-06-2025
- Politics
- Shafaq News
Syrian Kurdish Network presses for journalist's release
Shafaq News – Damascus The Syrian Kurdish Journalists Network on Saturday demanded the immediate, unconditional release of journalist Hassan Zaza, who was detained without explanation. According to the network, General Security forces first arrived at Zaza's family home in the Rukn al-Din neighborhood of Damascus on Friday while he was away, then arrested him around 5 p.m. His relatives have received no information about his whereabouts or the reasons for his detention. Zaza, a member of the General Council of the Free Media Union and Syria's representative to the International Federation of Arab Journalists, suffers from chronic illnesses requiring regular medical care, a relative told Shafaq News. The Journalists Network condemned the arrest as a violation of press freedom and protections guaranteed by the Universal Declaration of Human Rights and the International Covenant on Civil and Political Rights, urging authorities to clarify the grounds for Zaza's detention and to ensure journalists can work free from arbitrary interference. In May, security forces briefly detained Channel 8 journalist Akram Saleh and cameraman Joudi Haj Ali while covering clashes in Sahnaya near Damascus — an incident the Syrian Information Minister later described as a mistake.
Japan Today
20-06-2025
- Health
- Japan Today
'Gas station heroin' is technically illegal and widely available. Here are the facts
By MATTHEW PERRONE Health officials want you to think twice before buying one of those brightly colored little bottles often sold at gas stations, convenience stores and smoke shops. Sometimes called 'gas station heroin,' the products are usually marketed as energy shots or cognitive supplements but actually contain tianeptine, an unapproved drug that can be addictive and carries risks of serious side effects. U.S. poison control centers have reported a steady rise in calls linked to the drug for more than a decade. And last month the Food and Drug Administration sent a warning to health professionals about 'the magnitude of the underlying danger or these products.' Here's what to know about gas station heroin. Tianeptine is approved in a number foreign countries as an antidepressant, usually as a low-dose pill taken three times a day. But it has never been approved by the FDA for any medical condition in the U.S. Additionally, the drug cannot legally be added to foods and beverages or sold as a dietary supplement — something the FDA has repeatedly warned U.S. companies about. Still, under-the-radar firms sell tianeptine in various formulas, often with brand names like Zaza, Tianaa, Pegasus and TD Red. Although that is technically illegal, the FDA does not preapprove ingredients added to supplements and beverages. 'It's kind of this grey area of consumer products, or supplements, where the contents are not regulated or tested the way they would be with a medication,' said Dr. Diane Calello of the New Jersey Poison Information and Education System. Last year, Calello and her colleagues published a study documenting a cluster of emergency calls in New Jersey tied to a flavored elixir called Neptune's Fix. People experienced distress, rapid heartbeat, low blood pressure and seizures after drinking it. More than a dozen of the 20 patients had to be admitted for intensive care. Many tianeptine products claim— without evidence or FDA approval— to help users treat medical conditions, including addiction, pain and depression. In 2018, the FDA issued a warning letter to the maker of a product called Tianna, which claimed to provide 'an unparalleled solution to cravings for opiates.' While tianeptine is not an opioid, the drug binds to some of the same receptors in the brain, which can temporarily produce effects akin to oxycodone and other opioids. Tianeptine also carries some of the same physiological risks of opioids, including the potential to dangerously depress breathing. 'That's what tends to get people into trouble,' said Dr. Hannah Hays of Nationwide Children's Hospital in Columbus, Ohio. 'They use it for opioid-like effects or to self-treat opioid withdrawal and that can lead to slow breathing and problems like that." People dealing with opioid addiction, pain, depression, anxiety and other conditions should see a health professional to get a prescription for FDA-approved treatments, Hays said. Experts aren't sure but national figures show a big rise in emergency calls involving the drug. Calls to poison control centers increased 525% between 2018 and 2023, according to a data analysis published earlier this year. In about 40% of cases, the person had to seek medical care, with more than half of them needing critical care. One explanation for the rise in calls is simply that more Americans are using the products. But experts also say that the products are triggering more emergencies as they become more potent and dangerous. And the researchers in New Jersey who analyzed Neptune's Fix found that the liquid also contained synthetic cannabis and other drugs. 'You never quite know what's in that bottle," Calello said. 'It's important for people to know that even if they have used a product before, they could get a bottle that contains something very different from what they're looking for.' Tianeptine is not included in the federal Controlled Substances Act, which bans or restricts drugs that have no medical use or have a high potential for abuse, such as heroin, LSD and PCP. But about a dozen states have passed laws prohibiting or restricting tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee. In some cases, those laws have led to more cases of withdrawal among users of tianeptine, which can be chemically addictive. But state data also shows some success in reducing harm tied to the drug. Until recently, Alabama had the highest rate of tianeptine-related calls in the southern U.S., which increased more than 1,400% between 2018 to 2021. But after the state restricted tianeptine in 2021 calls began modestly decreasing while calls across other southern states continued to climb. © Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Newsweek
17-06-2025
- Health
- Newsweek
What Is Tianeptine? Warning Issued Over 'Gas Station Heroin'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. The U.S. Food and Drug Administration (FDA) has stepped up warnings about tianeptine, an unapproved antidepressant increasingly sold in gas stations and convenience stores under names like "Zaza," "Tianna," and "Neptune's Fix." The substance, dubbed "gas station heroin" for its opioid-like effects, is illegal and not approved for medical use in the U.S., although it is legally marketed in some countries as an antidepressant. Why It Matters Tianeptine can be found in some gas stations and convenience stores, often with packaging that mimics legal supplements. Its misuse has drawn increasing attention, particularly due to the way it mimics the effects of opioids, and can cause serious and even fatal side effects. According to the FDA, poison control center cases involving tianeptine exposure causing severe side effects have increased nationwide, from 11 in total between 2000 and 2013 to 151 in 2020 alone. What To Know Despite being illegal, the drug is sometimes illicitly added to foods and beverages or sold as a dietary supplement in the U.S. by some firms. An FDA spokesperson told Newsweek: "The FDA has taken steps to protect people from tianeptine products, including warning consumers that tianeptine is an unsafe food additive." The administration has also issued warning letters to companies distributing and selling unlawful tianeptine products, and issued import alerts to stop tianeptine shipments at the border. A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine. A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine. Uncredited/FDA Office of Regulatory Affairs, Health Fraud Branch via AP What Is Tianeptine? Tianeptine acts on the brain's opioid receptors, which can produce feelings of euphoria at high doses, and the products feature claims—without evidence or FDA approval—that they can help users treat medical conditions, including addiction, pain and depression. "Tianeptine has been used in tens of millions of patients over decades in Europe, Asia and South America and is well documented to be an antidepressant with efficacy roughly similar to first-line antidepressants," Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek. Tianeptine is taken recreationally by some, and has been used to self-treat a variety of ailments, as well as being used chronically. However, abruptly stopping it use can induce withdrawal symptoms similar to those associated with opioids, such as craving, sweating, diarrhea, and others. "Despite this, it has a remarkably safe track record in Europe and the abuse rate when used clinically is extremely low," Javitch said. He also said that used clinically, "there is no immediate perceptible effect on mood," and patients do not experience euphoria. Javitch specializes in experimental therapeutics in psychiatry and is a professor of molecular pharmacology and therapeutics at Columbia. "Doses six times the clinical dose were shown not to produce euphoria, and thus tianeptine works over time through changing brain chemistry and circuitry and synaptic structure," he said. However, he added that taking high doses in "an uncontrolled way is problematic." Javitch stressed that he did not believe products containing tianeptine should be sold in "an uncontrolled way with little oversight over dosing or combination with other medication." According to the FDA, reported adverse effects can include agitation, coma, confusion, death, drowsiness, hypertension, nausea, difficulty breathing, sweating, tachycardia (irregular heartbeat) and vomiting. In 2024, there was a cluster of illnesses in New Jersey associated with the product "Neptune's Fix," which was found to contain tianeptine and synthetic cannabinoid receptor triggers. Adverse effects included tachycardia, seizure and even death. FDA Crackdown The FDA has been taking frequent steps in recent years to warn the public about the dangers of the drug, as well as trying to crack down on companies that include the ingredient in their products. The agency recommends that health care professionals "encourage patients to avoid all products containing tianeptine, including those claiming to treat an ailment or disorder." Instead, the FDA said they should speak to their patients about evidence-based treatment options for opioid use disorder, or cases of depression, anxiety, or pain. States are also taking action independently, and currently a dozen have banned or restricted the sale of tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee. What People Are Saying Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek: "I don't think it should be available at gas stations in an uncontrolled way with little oversight over dosing or combination with other medication. I fear that people will use much higher doses than are clinically indicated, and can escalate dosing and mix with other compounds." He added: "We just have to remember that tianeptine may have major potential as a treatment for depression and anxiety in the right patients, and we are trying to develop a precision psychiatry approach to predicting just which patients will respond to the mediation when used appropriately." Commissioner of Food and Drugs Dr. Martin Makary said in a note last month on the subject: "I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth. "While the FDA is closely following the distribution and sale of these products, it is critical that you appreciate the magnitude of the underlying danger of these products, and disseminate information about it." He added: "Historically, there has been a delayed recognition of fast-growing trends, such as opioid abuse and vaping addiction in youth. Let's be proactive in understanding and addressing the use of tianeptine products, which are available even to our nation's youth." What Happens Next The FDA said it will continue working with local and federal partners to crack down on illegal tianeptine products. It also urged consumers to report any adverse reactions involving tianeptine to the agency's MedWatch program. This article contains reporting by The Associated Press.
